Trientine hydrochloride capsule manufacturer and product quality introduction

Trientine Hydrochloride is an oral copper chelator that is widely used to treat copper metabolism disorders such as Wilson's Disease. As an important alternative drug after penicillamine (Penicillamine), it is especially suitable for patients who are intolerant to penicillamine or have severe adverse reactions. With the continuous expansion of clinical applications, the market demand for trientine hydrochloride has increased year by year, and many pharmaceutical companies at home and abroad have begun to put into production. This article will focus on introducing the main manufacturers of trientine hydrochloride capsules and their product quality status to help patients and clinicians better understand the source and quality assurance of drugs.

1. Introduction to major international manufacturers and brands

1.Waymade(UK)

Waymade is one of the earliest manufacturers in Europe to produce trientine hydrochloride. Its products are mainly sold in the UK, Germany and other EU countries, and have obtained UK MHRA and EU EMA certifications. Waymade’s trientine hydrochloride capsules are known for their stable quality and accurate efficacy. They are widely used clinically in Europe and are one of the routine treatment options for patients with Wilson’s disease. Its dosage form is usually 250mg capsule packaging, and each bottle 100 capsules. The market price is high, but the efficacy is reliable, and it is one of the internationally recognized brands.

2.Teva (Israel/Global)

Teva is the world's leading manufacturer of generic and patented drugs, with extensive markets in the United States, Europe and Asia. Teva’s trientine products occupy a certain share in the European and American pharmaceutical markets. They have been approved by FDA and EMA and have high pharmaceutical standards. TevaThe advantages of Teva’s products lie in its mature quality system, stable supply chain, and relatively moderate price. It is often used as a designated brand in European and American hospitals and large chain pharmacies.

3.Orphalan(France)

Orphalan is a European biopharmaceutical company focusing on the treatment of rare diseases. Its productCufence(Trientine hydrochloride) is one of its representative drugs. The company is committed to improving the treatment experience of patients with rare diseases. Its products have strong influence in the high-end markets of Europe and the United States, emphasizing traceability and personalized treatment recommendations. Although the price is on the high side, it performs well in terms of drug consistency and patient tolerability.

2. Asian and generic drug manufacturers

1.India Natco Pharma / MSN Laboratories

With the development of generic drug technology, many Indian pharmaceutical companies have begun to get involved in the production of generic drugs of trientine hydrochloride. Among them, Natco and MSN Laboratories are registered with WHO and the United States FDA. The Indian generic version of trientine has passed the bioequivalence evaluation in terms of ingredient consistency and clinical equivalence. Although it has not yet been officially registered in mainland China, it is widely welcomed in the Asian and African markets. The price of the Indian version is significantly lower than that of the European and American original drugs, making it an economical option that some patients consider when going abroad or purchasing on behalf of others.

2.Lucius Pharmaceuticals

Lucius Pharmaceuticals is a generic drug brand that has emerged in Asia in recent years. Its trientine hydrochloride generic version has gained a certain market share due to its low price and sufficient supply. Although its clinical application data is relatively limited, some channels claim that its drug ingredients are highly consistent with the original drug. Before being included in the domestic drug approval system, patients who obtain such generic drugs through overseas medical intermediaries or cross-border drug purchase platforms need to be cautious and pay attention to the legality of the channels and the authenticity of the drugs.

3. Domestic import and registration status

As of2025, trientine hydrochloride capsules have obtained registration and marketing approval in mainland China, but have not yet been included in the national medical insurance directory. At present, most of the products sold in China are original European drugs or registered drugs introduced through import agents. They are mainly available in tertiary hospitals, specialist hospitals and some high-end chain pharmacies. Since the drug is a drug for rare diseases, the price is relatively high (for example, a bottle of 200 mg × 100 tablets produced in Germany costs about 40,000 yuan), which still poses a considerable financial burden to patients.

There are no domestic generic drugs registered and marketed by the National Food and Drug Administration (NMPA), but some local pharmaceutical companies (such as Huahai Pharmaceuticals, Qilu Pharmaceuticals, etc.) have carried out related research and development projects. It is expected that domestic generic versions will be approved in the future, which will greatly improve market accessibility and help reduce prices.

4. Product quality assessment and usage suggestions

1. Advantages of original research drugs

Trientine capsules produced by original drugs such as Waymade, Teva, Orphalan are more reliable in terms of quality standards, production processes, stability and consistency, and have sufficient clinical verification data. They are suitable for patients with high requirements for efficacy stability, especially for long-term maintenance treatment groups.

2. Generic drugs need to strictly control their channels

Although generic drugs in India, Laos and other regions are more affordable, there may be uncertainties in quality supervision, storage and transportation conditions, and drug consistency. If patients need to use generic drugs, it is recommended to obtain them through formal cross-border medical service platforms or under the guidance of a doctor to ensure drug safety.

3. Storage and usage precautions

Trientine hydrochloride should be stored in a dry, dark place to avoid deterioration due to moisture. The medicine should be taken on an empty stomach, and avoid taking it with metal ions (such as iron and zinc) in food to avoid affecting absorption. During the period of medication, liver and kidney functions and blood copper levels should be monitored regularly to evaluate drug efficacy and toxic reactions.

Trientine hydrochloride, as the core treatment drug for Wilson's disease, has been put into production by many internationally renowned pharmaceutical companies such as Waymade, Teva and Orphalan, and its product quality has been widely recognized internationally. Although Asian generic drugs, such as the Indian and Lao versions, have economic advantages, you need to carefully choose reliable channels before using them. As the country attaches greater importance to rare disease drugs, it is expected that more local companies will join the ranks of generic drug production in the future. During the medication process, patients should make drug selection and treatment planning under the guidance of a professional doctor to ensure the safety and long-term effects of treatment.

Reference materials:https://www.drugs.com/